• On 27 June 2026, Mirion Technologies, Inc. (NYSE:MIR) was added to a range of Russell indices, including Russell 3000 and Russell 2000 value and defensive benchmarks, broadening its index footprint after the reconstitution.
• This broad inclusion across value, growth, and defensive small-cap indices places Mirion on the radar of a wider base of index-tracking and quantitatively driven investors.
• We’ll now examine how Mirion’s addition to multiple Russell value and defensive indices may influence its longer-term investment narrative.

The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 16 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

Mirion Technologies Investment Narrative Recap

To own Mirion, you need to believe in a sustained need for radiation detection, monitoring, and nuclear infrastructure upgrades across power, medical, and research end markets. Its broad addition to Russell value and defensive indices could modestly increase visibility and trading liquidity, but does not directly change the key near term catalyst, which is converting its strong nuclear and digital pipeline into profitable growth, nor the main risk around concentration in long cycle nuclear projects and policy exposure.

The most relevant recent announcement alongside the index inclusions is Mirion’s reaffirmed 2026 revenue growth outlook of about 22% to 24%, which already incorporates FX and acquisition benefits. Together, higher index visibility and a higher growth profile may sharpen investor focus on execution, especially around integrating acquisitions like Certrec, scaling new digital and AI offerings, and managing the risk that nuclear modernization or policy trends could slow sooner than the market expects.

Yet behind the broader index recognition, investors should also be aware of the concentration risk tied to nuclear policy and reactor life extension...

Mirion Technologies' narrative projects $1.4 billion revenue and $145.5 million earnings by 2029.

Uncover how Mirion Technologies' forecasts yield a $27.90 fair value, a 70% upside to its current price.

Exploring Other Perspectives

Four members of the Simply Wall St Community currently place Mirion’s fair value between US$16.04 and US$27.90, highlighting very different expectations. When you compare those views with the reliance on nuclear modernization and life extension as a key growth driver, it is worth weighing how sensitive your own outlook is to shifts in long term nuclear policy and project pipelines.

Explore 4 other fair value estimates on Mirion Technologies - why the stock might be worth as much as 70% more than the current price!

The Verdict Is Yours

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Mirion Technologies research is our analysis highlighting 3 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Mirion Technologies research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Mirion Technologies' overall financial health at a glance.

Searching For A Fresh Perspective?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

• The future of work is here. Discover the 30 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• Capitalize on the AI infrastructure supercycle with our selection of the 52 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.